Investigation on Intestinal Proteins and Drug Metabolizing Enzymes in Simulated Microgravity Rats by a Proteomics

Huayan Liu1, Jingjing Guo1, Yujuan Li1

  • 1School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing 100081, China.

Insights

Simulated microgravity significantly altered intestinal drug metabolizing enzymes (IDMEs) in rats, impacting protein expression and activity. This finding suggests potential changes in oral drug efficacy and safety for astronauts in space.

Area of Science:

  • Proteomics
  • Space Biology
  • Pharmacology

Background:

  • Intestinal drug metabolizing enzymes (IDMEs) are crucial for oral drug efficacy and safety.
  • Understanding how microgravity affects these enzymes is vital for astronaut health and medication use.
  • Previous research has not fully elucidated the impact of microgravity on intestinal protein metabolism.

Purpose of the Study:

  • To investigate changes in intestinal mucosa proteins, particularly IDMEs, after 14-day simulated microgravity.
  • To assess the expression and activity of key drug-metabolizing enzymes under simulated microgravity conditions.
  • To provide preliminary data on the effects of microgravity on intestinal metabolism.

Main Methods:

  • Utilized the Morey-Holton tail-suspension analog to simulate microgravity.
  • Employed label-free quantitative proteomic strategy to analyze intestinal mucosa proteins in rats.
  • Confirmed protein expression via Western-blot and evaluated enzyme activity (ADH, ALDH, GST).

Main Results:

  • Identified 335 differentially expressed proteins (DEPs), with 190 upregulated and 145 downregulated.
  • Found significant alterations in the expression of key IDMEs: CYP1A2, CYP2D1, CYP3A2, ADH1 (decreased), and GSTM5 (upregulated).
  • Observed a reduction in alcohol dehydrogenase (ADH) activity, while aldehyde dehydrogenase (ALDH) and glutathione S-transferase (GST) activities remained largely unchanged.

Conclusions:

  • Simulated microgravity significantly impacts the expression and activity of specific intestinal drug metabolizing enzymes.
  • These alterations may affect the efficacy and safety of orally administered drugs in microgravity environments.
  • The study offers insights into intestinal health and medication considerations for astronauts.